Charlie Carter
- Indexed articles, last 90 days
- 7
- Latest publication
- Aug 26, 2026
- Outlet visibility, for Selectscience
- Top 5M sites
- Earliest in this view
- Jul 20, 2026
Latest articles
Key questions to refine your bioconjugation strategy - SelectScience interview (opens the original)
Read excerpt
Bioconjugation works by joining two or more molecules together, usually through a covalent bond, to create a single entity that carries the combined properties of its parts. Doing it well means choosing the right chemistry, conjugation site, and linker for the job. Get that combination wrong, and the result may be an inefficient reaction, poor stability, unwanted aggregation or a conjugate that performs well in vitro but fails in vivo. Because the components are produced separately and joined af
Automate 3D cell culture workflows with liquid handling - SelectScience guide (opens the original)
Read excerpt
Advanced cell culture models, including 3D cell cultures, hydrogels, organoids, and iPSC-derived cultures, provide more physiologically relevant results than traditional 2D models. However, routine processes such as matrix preparation, media exchange, cell feeding, and sample collection can be difficult to perform consistently, introducing variability and impacting experimental outcomes. As labs adopt more standardized and automated cell culture workflows, liquid handling becomes essential for i
What scientists want from raw materials suppliers - SelectScience article (opens the original)
Read excerpt
A recent market survey of professionals working across academic research, diagnostics, biotechnology, pharmaceutical and government labs set out to understand how scientists source the chemical raw materials, reagents and fine chemicals their work depends on. The results paint a clear picture of what buyers prioritize, where current suppliers fall short, and which materials are proving hardest to obtain. In this SelectScience® article, we look at what the survey reveals about scientist prioritie
New approach methodologies and human-centric drug discovery - SelectScience news (opens the original)
Read excerpt
More than 90% of drug candidates that succeed in preclinical development ultimately fail in clinical trials. The reasons are complex, but the scale of attrition exposes a fundamental weakness in how new medicines are developed: the industry remains heavily dependent on models that do not adequately reflect human biology. For nearly 80 years, animal studies have been treated as the gold standard in preclinical drug development. Yet mounting evidence suggests that they often provide a poor represe
Compact liquid handling boosts lab automation access - SelectScience interview (opens the original)
Read excerpt
Manual pipetting is the basis of most routine lab work, and it is also one of the easiest places for error, variation, and strain to creep in. For many labs, access to automation has traditionally been limited by space, infrastructure requirements, and implementation complexity. Today's compact liquid handling platforms are helping to expand access to automation, enabling more labs to improve reproducibility, efficiency, and workflow consistency. Repetitive pipetting is an integral part of every
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Selectscience, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.